Screener
Moderna MRNA Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$782M+5.2% | -$1.34B-38.3% | -$826M+26.3% | -$200M-1,638% | -$825M+35.5% | ||
| $63M+10.5% | $59M+51.3% | $67M+11.7% | $52M0.0% | $57M+39.0% | ||
| $120M-7.7% | $104M-9.6% | $113M+8.7% | $125M+11.6% | $130M+16.1% | ||
| -$526M+42.8% | -$630M+39.2% | —— | -$847M+45.9% | -$919M+27.9% | ||
| $37M+1,133% | $62M-47.0% | $39M-92.5% | $33M-78.1% | $3M-98.4% | ||
| $329M-41.7% | -$76M-110% | $0— | $700M-2.9% | $564M-65.8% | ||
| —— | —— | $150M— | $150M— | $150M— | ||
| $14M+55.6% | $17M+325% | $581M— | $0-100% | $9M-73.5% | ||
| -$185M+46.4% | -$688M-127% | $1.46B— | -$147M+82.4% | -$345M— | ||
| -$563M+38.9% | -$692M+40.0% | —— | -$880M+48.7% | -$922M+36.7% |
FAQ
- How much cash does Moderna generate?
- Moderna (MRNA) generated -$2.9B in operating cash flow over the trailing twelve months.
- What is Moderna's free cash flow?
- After $171.0M of capital expenditures, Moderna's free cash flow was -$3.1B over the trailing twelve months, up 29.3% year over year.
- Where does Moderna's cash flow data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
